Your Article Summary
A long-term follow-up of botulinum toxin A in cervical dystonia
Neurological Research, 07/02/09
Mohammadi B et al. - These data confirm the efficacy and safety of BoNT-A treatment in CD over an extended period of up to 14 years.
Related Articles
Paramedical treatment in primary dystonia: A systematic review
Movement Disorders, 10/30/09
Relevance Score: 66%
Neck movement speed in cervical dystonia
Movement Disorders, 10/30/09
Relevance Score: 65%
Cervical dystonia
Future Neurology, 10/12/09
Relevance Score: 64%
A Severe Case of Complex Regional Pain Syndrome I (Reflex Sympathetic Dystrophy) Managed with Spinal Cord Stimulation
Pain Practice, 10/27/09
Relevance Score: 63%
Cervical Radicular Pain
Pain Practice, 10/07/09
Relevance Score: 47%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/18/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome
Journal of Thrombosis and Haemostasis, 12/18/09
Enhanced frontal function in Parkinson’s disease
Brain, 12/18/09
Wheelchair Repairs, Breakdown, and Adverse Consequences for People With Traumatic Spinal Cord Injury
Archives of Physical Medicine and Rehabilitation, 12/18/09

See Latest Articles